Found 328 matching trials
A Study of Atezolizumab (Anti-Programmed Death-Ligand 1 [PD-L1] Antibody) Alone or in Combination With an Immunomodulatory Drug and/or Daratumumab in Participants With Multiple Myeloma (MM) PHASE1 This multicenter, open-label, Phase I study will evaluate the safety, effic...
Show More Location
University of Alabama at Birmingham
Learn More & Join Trial
CC-4047 in Treating Patients With Myelofibrosis PHASE1 RATIONALE: Biological therapies, such as CC-4047, may stimulate the immune ...
Show More Learn More & Join Trial
A Study of Oprozomib, Pomalidomide, and Dexamethasone in Adults With Primary Refractory or Relapsed and Refractory Multiple Myeloma PHASE1 The purpose of the Phase 1 part of the study is to determine the maximum to...
Show More Location
California Cancer Associates For Research and Exellence, cCare
Learn More & Join Trial
Pomalidomide in Relapsed and Refractory Multiple Myeloma (RRMM) PHASE2 This study is determining whether the addition of cyclophosphamide to pomal...
Show More Status
Active Not Recruiting
Location
Belfast Health & Social Care Trust
Learn More & Join Trial
Marizomib Central Nervous System (CNS) PHASE2 This research is being done to test whether the investigational drug marizo...
Show More Location
Massachusetts General Hospital Cancer Center
Learn More & Join Trial
Efficacy and Safety Study of CC-4047 (Pomalidomide) to Treat Advanced Soft Tissue Sarcoma PHASE2 The purpose of the study is to determine the safety and efficacy of single ...
Show More Location
Sarcoma Oncology Center
Learn More & Join Trial
Teclistamab in Combination With Pomalidomide Administered in Alternative Fashion in Participants With Relapsed or Refractory Multiple Myeloma. PHASE2 This Phase II, open-label, multicenter study will evaluate teclistamab in c...
Show More Learn More & Join Trial
Efficacy and Safety of Pomalidomide in Combination With Low-dose Dexamethasone in Chinese Patients With Relapsed and Refractory Multiple Myeloma PHASE3 This study aims to assess the efficacy and safety of pomalidomide in combin...
Show More Location
Blood Diseases Hospital Chinese Academy of Medical Sciences
Learn More & Join Trial
Selinexor, Cyclophosphamide and Prednisone in Myeloma PHASE2 The trial is designed as a randomised, controlled, open, parallel group, mu...
Show More Location
Birmingham Heartlands Hospital
Learn More & Join Trial
Leflunomide, Pomalidomide, and Dexamethasone for the Treatment of Relapsed or Refractory Multiple Myeloma PHASE2 This phase II trial studies how well leflunomide, pomalidomide, and dexamet...
Show More Location
City of Hope Medical Center
Learn More & Join Trial